C G Hanratty
Overview
Explore the profile of C G Hanratty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilson W, Walsh S, Bagnall A, Yan A, Hanratty C, Egred M, et al.
Catheter Cardiovasc Interv
. 2017 Mar;
90(5):703-712.
PMID: 28296045
We aimed to determine clinical outcomes 1 year after successful chronic total occlusion (CTO) PCI and, in particular, whether use of dissection and re-entry strategies affects clinical outcomes. Hybrid approaches...
2.
Wilson W, Walsh S, Yan A, Hanratty C, Bagnall A, Egred M, et al.
Heart
. 2016 May;
102(18):1486-93.
PMID: 27164918
Objectives: Treatment options for coronary chronic total occlusions (CTO) are limited, with low historical success rates from percutaneous coronary intervention (PCI). We report procedural outcomes of CTO PCI from 7...
3.
Sharma V, Jadhav S, Harcombe A, Kelly P, Mozid A, Bagnall A, et al.
Open Heart
. 2015 Apr;
2(1):e000228.
PMID: 25852949
Objective: To assess the impact of proctoring for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in six UK centres. Methods: We retrospectively analysed 587 CTO procedures from six UK...
4.
Morgan D, Silke B, Dixon L, Allen P, Hanratty C, McVeigh G
Eur J Clin Pharmacol
. 2003 May;
59(3):195-9.
PMID: 12756513
Aims: To evaluate the effects of the intravenous administration of the nitric oxide synthesis inhibitor N(g)nitro-L-arginine methyl ester (L-NAME) in healthy volunteers. Methods: L-NAME (0.25, 0.5 and 0.75 mg/kg over...
5.
Morgan D, Hanratty C, Dixon L, Trimble M, OKeeffe D
Europace
. 2002 Jul;
4(3):281-7.
PMID: 12134974
The embryological development of the superior vena cava (SVC) is complex. If the left common cardinal vein fails to occlude it can, along with the left duct of Cuvier form...
6.
McGrath L, McCall D, Hanratty C, Brennan S, Devine A, McCauley D, et al.
Clin Sci (Lond)
. 2001 Oct;
101(5):507-13.
PMID: 11672456
Heightened systemic oxidative stress is increasingly recognized as a feature of cystic fibrosis (CF). The consequences of long-term exposure to free radical attack include a predisposition to diseases such as...
7.
8.
Hanratty C, McGrath L, McAuley D, Young I, Johnston D
BMC Cardiovasc Disord
. 2001 Jul;
1:1.
PMID: 11444999
Background: Manipulation of total homocysteine concentration with oral methionine is associated with impairment of endothelial-dependent vasodilation. This may be caused by increased oxidative stress. Vitamin C is an aqueous phase...
9.
McVeigh G, Allen P, Morgan D, Hanratty C, Silke B
Clin Sci (Lond)
. 2001 Mar;
100(4):387-93.
PMID: 11256976
Traditionally, nitric oxide-mediated alteration in blood vessel tone has been inferred from changes in flow in response to physical and pharmacological interventions using plethysmographic or ultrasonic techniques. We hypothesized that...
10.
Hanratty C, McGlinchey P, Johnston G, Passmore A
Drugs Aging
. 2001 Feb;
17(5):353-62.
PMID: 11190416
Digoxin remains one of the most commonly prescribed of all cardiac medications. The main indications for digoxin usage include atrial fibrillation and heart failure; both these conditions are more prevalent...